Clinical Trial Update: Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression. [Phase 3]

View source ↗

Summary

A Phase 3 long-term safety study of venlafaxine extended-release (Effexor XR) in adults with major depressive disorder has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Effexor XR (venlafaxine)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Depression | Phase 3 | Status: COMPLETED